Positioning no disclosures inside 60 days, left as found
Options put/call open interest 29.94, read 2026-11-07
Ethical screen not yet scored
Price40.26 USD
Fair value43.86
Ethical score70.0/100
Value readFairas of 6 Nov 2026
Our investment reviews on this name
2026-11-04Read Distribution46.99-14.3% to today ✓Markdown gives way to Distribution
2026-10-18Read Markdown44.78-10.1% to today ✓Markup gives way to Markdown after a 13% slide in 7 days
2026-10-11Read Markup51.50-21.8% to today Accumulation gives way to Markup first Markup read since July
2026-10-02Read Accumulation51.50-21.8% to today Distribution gives way to Accumulation after a 13% slide in 8 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Power Integrations, Inc. holds its Distribution at $40.26. Elevated stress, defensive posture warranted, held for 1 days.
As held on the ledger · 2026-11-06
Phase
Distribution · caution
Quantitative state
Elevated stress, defensive posture warranted, held for 1 days
Price at the screen
$40.26
Valuation
106.36 trailing · 25.16 forward price to earnings
Values screen
Not scored· score 70.0
Beta
1.57
The Workings
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
Excluded
Below 33%
Interest-bearing debt is of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
24.70%
Below 33%
Cash held in interest-bearing accounts and securities is 24.7% of assets, under the one-third limit.
Pass
Receivables
9.97%
Below 49%
Money owed to the company is 10.0% of assets, under the 49% limit.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
The Read, in Plain English
Power Integrations, clears the business-activity screen and the figures we can measure look clean, but its debt figure is still pending, so the verdict is not final yet.
Read as at 2026-11-07. It updates when the underlying figures move, and past reads are kept below.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Fair vs our fair value, as of 6 Nov 2026: it trades at roughly an 8% discount to our $43.86 fair value, 2.70% revenue growth.
Fair value range in USD, drawn from the 2026-11-06 screen. The gold marker is the market price at the same screen. A 8.2% discount to the base estimate.
Where our models see it going: fair-value estimate $43.86, with a range of $43.86 to $50.44, dated to the 2026-11-06 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Everyday Gadget Chips but Weak Returns Ahead
Every phone charger and industrial motor relies on high-voltage conversion chips to keep humming, yet Power Integrations shows little ability to turn that demand into reliable profit. The shares trade at 70 dollars against a fair value nearer 50, with a forward multiple of 38 times on revenue growth of just 3 percent, profit margins of 4 percent and return on equity at 2 percent. In a cyclical semiconductor business that already carries an unknown moat, those figures point to a valuation that prices in far more stability than the numbers support.
This is the classic cyclical value trap in action. Low multiples can look tempting when earnings sit near a peak, yet here the multiple stays elevated while growth and returns stay depressed. The ethical screen clears, but that alone does not create an investment case when the underlying economics remain thin.
Margin pressure from inventory swings and customer concentration can hit hard in downturns, and any rebound may prove fleeting once the cycle turns again. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
POWI trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 7.1% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 30%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (4 analysts) rates it none, with a mean price target of $70. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-03Markdown$43.86+0.0%Entry 16
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 30%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (4 analysts) rates it none, with a mean price target of $70. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-02Markdown$43.86+0.0%Entry 15
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 30%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (4 analysts) rates it none, with a mean price target of $70. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-01Markdown$43.86-6.6%Entry 14
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 6.6% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 30%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (4 analysts) rates it none, with a mean price target of $70. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-31Markdown$46.98+0.0%Entry 13
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 30%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (4 analysts) rates it none, with a mean price target of $70. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-30Markdown$46.98+0.0%Entry 12
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 30%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (4 analysts) rates it none, with a mean price target of $70. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-29Markdown$46.98+0.0%Entry 11
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 30%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (4 analysts) rates it none, with a mean price target of $70. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-28Markdown$46.97+0.0%Entry 10
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 30%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (4 analysts) rates it none, with a mean price target of $70. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Markdown$46.97+4.9%Entry 9
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 4.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 30%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (4 analysts) rates it none, with a mean price target of $70.
2026-10-18Markdown · changed$44.78-13.0%Entry 8
The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 13.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 85% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 30%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (4 analysts) rates it none, with a mean price target of $70.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
